This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / Regulatory / Regencell Bioscience Securities...
Regulatory securities fraud lawsuit

Regencell Bioscience Securities Fraud Lawsuits

Analysis based on 206 articles · First reported Apr 25, 2026 · Last updated Jun 18, 2026

Sentiment
-80
Attention
6
Articles
206
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The ongoing class action lawsuits and the United States — United States Department of Justice investigation into Regencell Bioscience Holdings for alleged market manipulation and misleading statements have severely impacted investor confidence. The company's stock price has already fallen significantly, and further legal and regulatory actions could lead to additional financial penalties and reputational damage, negatively affecting its market valuation. This event highlights the risks associated with investing in companies with volatile share prices and potential compliance issues.

biotechnology legal services
Event Summary

Regencell Bioscience Holdings is facing multiple class action lawsuits from various investor-rights law firms, including Bronstein, Gewirtz & Grossman, LLC, Glancy Prongay & Murray, Faruqi & Faruqi, Rosen Law Firm, Levi & Korsinsky, The Gross Law Firm, and Law Offices of Howard G. Smith. These lawsuits allege that Regencell Bioscience Holdings made materially false and misleading statements between October 28, 2024, and October 31, 2025, regarding its business, operations, and compliance policies. Specifically, the complaints claim that Regencell Bioscience Holdings was vulnerable to market manipulation, which exposed investors to significant financial risk and subjected the company to heightened regulatory scrutiny. The United States — United States Department of Justice is also conducting an investigation into the trading of Regencell Bioscience Holdings' ordinary shares, requesting relevant documents and communications. This news led to an 18.56% drop in Regencell Bioscience Holdings' stock price on November 3, 2025. Investors who suffered losses are being encouraged to join these class actions, with a lead plaintiff deadline set for June 23, 2026.

Entities Involved
stock
Regencell Bioscience Holdings
Regencell Bioscience Holdings is the primary defendant in multiple class action lawsuits alleging securities fraud due to market manipulation and undisclosed risks, leading to significant financial and reputational harm. The company is also under investigation by the United States — United States Department of Justice.
Importance 100.0 Sentiment -85.0
govactor
United States — United States Department of Justice
The United States — United States Department of Justice is conducting an investigation into the trading of Regencell Bioscience Holdings' ordinary shares, indicating potential regulatory and enforcement action.
Importance 95.0 Sentiment 0.0
priv
Levi & Korsinsky
Levi & Korsinsky is the law firm that filed the class action lawsuit against Regencell Bioscience Holdings, representing aggrieved shareholders and seeking to recover losses.
Importance 90.0 Sentiment 70.0
priv
Rosen Law Firm
Rosen Law Firm is actively representing investors in a class action lawsuit against Regencell Bioscience Holdings, seeking to recover damages for alleged securities fraud.
Importance 90.0 Sentiment 20.0
priv
Faruqi & Faruqi
Faruqi & Faruqi is investigating potential claims against Regencell Bioscience Holdings and reminds investors of the deadline to seek lead plaintiff status in the federal securities class action.
Importance 85.0 Sentiment 20.0
priv
Bronstein, Gewirtz & Grossman, LLC
Bronstein, Gewirtz & Grossman, LLC has filed a class action lawsuit against Regencell Bioscience Holdings and its officers, alleging violations of federal securities laws.
Importance 80.0 Sentiment 20.0
priv
Glancy Prongay & Murray
Glancy Prongay & Murray is one of the law firms representing investors in the securities fraud class action lawsuit against Regencell Bioscience Holdings.
Importance 70.0 Sentiment 20.0
per
Joseph E. Levi
Joseph E. Levi, Esq. is a key contact at Levi & Korsinsky, LLP, actively involved in notifying investors and leading the class action lawsuit against Regencell Bioscience Holdings.
Importance 70.0 Sentiment 60.0
per
Philip Kim
Philip Kim, an attorney at Rosen Law Firm, is a key contact for investors interested in joining the class action lawsuit against Regencell Bioscience Holdings.
Importance 70.0 Sentiment 20.0
per
Lawrence Rosen
Lawrence Rosen, founding partner of Rosen Law Firm, is highlighted for his firm's success in securities class actions and its role in the Regencell Bioscience Holdings lawsuit.
Importance 70.0 Sentiment 20.0
priv
Robbins LLP
Robbins LLP is a law firm that has informed stockholders about a class action filed against Regencell Bioscience Holdings, alleging stock manipulation.
Importance 65.0 Sentiment 30.0
priv
The Law Offices of Frank R. Cruz
The The Law Offices of Frank R. Cruz is also representing investors in the securities fraud class action lawsuit against Regencell Bioscience Holdings.
Importance 60.0 Sentiment 20.0
per
Peretz Bronstein
Peretz Bronstein, Founding Partner of Bronstein, Gewirtz & Grossman, LLC, emphasizes the firm's commitment to restoring investor capital and ensuring corporate accountability in the Regencell Bioscience Holdings case.
Importance 60.0 Sentiment 20.0
per
Josh Wilson
Josh Wilson is a Securities Litigation Partner at Faruqi & Faruqi who is encouraging investors to contact him regarding their losses in Regencell Bioscience Holdings.
Importance 60.0 Sentiment 50.0
per
Yat-Gai Au
Yat-Gai Au is mentioned as holding a significant percentage of Regencell Bioscience Holdings' outstanding shares, which is highlighted in the context of the company's alleged market manipulation.
Importance 50.0 Sentiment -70.0
+ 7 more entities View on Dashboard
Relationships
Regencell Bioscience Holdings related ↔ United States — United States Department of Justice
United States — United States Department of Justice related ↔ Rosen Law Firm
United States — United States Department of Justice related ↔ Faruqi & Faruqi
United States — United States Department of Justice related ↔ Bronstein, Gewirtz & Grossman, LLC
United States — United States Department of Justice related ↔ Glancy Prongay & Murray
United States — United States Department of Justice related ↔ Philip Kim
United States — United States Department of Justice related ↔ Lawrence Rosen
Levi & Korsinsky related ↔ Rosen Law Firm
Levi & Korsinsky related ↔ Faruqi & Faruqi
Levi & Korsinsky related ↔ Bronstein, Gewirtz & Grossman, LLC
Levi & Korsinsky related ↔ Glancy Prongay & Murray
Levi & Korsinsky related ↔ Joseph E. Levi
Levi & Korsinsky related ↔ Philip Kim
Levi & Korsinsky related ↔ Lawrence Rosen
Rosen Law Firm competitor ↔ Faruqi & Faruqi Rosen Law Firm competes directly against Faruqi & Faruqi in the securities litigation space, as both firms regularly sol
+ 20 more relationships View on Dashboard
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.